Jeffrey Cummings, MD, ScD
Articles
Using Prior Success to Improve Alzheimer Trials, Drug Development: Jeffrey Cummings, MD, ScD
January 26th 2022The director of the Chambers-Grundy Center for Transformative Neuroscience at the University of Nevada, Las Vegas discussed how the momentum gained within the Alzheimer community can springboard success going forward. [WATCH TIME: 4 minutes]
Eliminating Wasteful Costs in Alzheimer Drug Development: Jeffrey Cummings, MD, ScD
January 5th 2022The director of the Chambers-Grundy Center for Transformative Neuroscience at the University of Nevada–Las Vegas detailed the steps necessary to lower wasted costs from Alzheimer disease drug development and improve regulatory success. [WATCH TIME: 4 minutes]
Encouraging Signs in Alzheimer Drug Development Despite Failures: Jeffrey Cummings, MD, ScD
December 3rd 2021The director of the Chambers-Grundy Center for Transformative Neuroscience at the University of Nevada–Las Vegas discussed the positive trends within the Alzheimer drug development space. [WATCH TIME: 2 minutes]
Jeffrey Cummings, MD, ScD: Repurposed Agents Within Alzheimer Disease Pipeline
August 24th 2020The director emeritus of the Lou Ruvo Center for Brain Health at Cleveland Clinic and vice chair of the Department of Brain Health at the University of Nevada-Las Vegas discussed the role repurposed agents play in Alzheimer disease development.
Jeffrey Cummings, MD, ScD: Greatest Unmet Needs in Alzheimer Disease
August 8th 2020The director emeritus of the Lou Ruvo Center for Brain Health at Cleveland Clinic and vice chair of the Department of Brain Health at the University of Nevada–Las Vegas discussed the leading challenges for those with Alzheimer disease.
Jeffrey Cummings, MD, ScD: Where Aducanumab Stands in Alzheimer Clinical Pipeline
July 29th 2020The director emeritus of the Lou Ruvo Center for Brain Health at Cleveland Clinic and vice chair of the Department of Brain Health at the University of Nevada­–Las Vegas gives his thoughts on the latest aducanumab update and its potential as a treatment for Alzheimer disease.
Jeffrey Cummings, MD, ScD: Trends in the Alzheimer Disease Clinical Pipeline
July 24th 2020The director emeritus of the Lou Ruvo Center for Brain Health at Cleveland Clinic and vice chair of the Department of Brain Health at the University of Nevada-Las Vegas, details trends in Alzheimer disease research over the past few years.
